p.126 抽出テキスト

25894416 267. Mahmoud KD, Sanon S, Habermann EB, et al. Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol 2016; 67: 1038-1049. PMID: 26940923 268. Holcomb CN, Graham LA, Richman JS, et al. The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting. J Am Coll Cardiol 2014; 64: 2730- 2739. PMID: 25541124 269. Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011; 97: 1566-1572. PMID: 21791513 270. Rossini R, Musumeci G, Capodanno D, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery: Results of a multicentre registry. Thromb Haemost 2015; 113: 272- 282. PMID: 25274620 271. Rossini R, Angiolillo DJ, Musumeci G, et al. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry. Catheter Cardiovasc Interv 2 0 1 7 ; 8 9 : E 1 3 -E 2 5 . PMID: 27404797 272. Smilowitz NR, Lorin J, Berger JS. Risks of noncardiac surgery early after percutaneous coronary intervention. Am Heart J 2019; 217: 64-71. PMID: 31514076 273. van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104: 1229-1234. PMID: 19840567 274. Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study. Circulation 2012; 126: 1355- 1362. PMID: 22893606 275. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2009; 2: 542-549. PMID: 19539259 276. Egholm G, Thim T, Olesen KK, et al. Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events. Thromb Haemost 2 0 1 6 ; 11 6 : 172-180. PMID: 27098806 277. Assali A, Vaknin-Assa H, Lev E, et al. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv 2 0 0 9 ; 7 4 : 8 3 7 - 8 4 3 . PMID: 19626693 278. Sanders RD, Bottle A, Jameson SS, et al. Independent preoperative predictors of outcomes in orthopedic and vascular surgery: The influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg 2012; 255: 901-907. PMID: 22504189 279. Hong SJ, Kim MJ, Kim JS, et al. Effect of Perioperative A n t i p l a t e l e t T h e r a p y o n O u t c o m e s i n P a t i e n t s Wi t h Drug-Eluting Stents Undergoing Elective Noncardiac Surgery. Am J Cardiol 2019; 123: 1414-1421. PMID: 30770090 280. Smith BB, Warner MA, Warner NS, et al. Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents. Anesth Analg 2019; 128: 621-628. PMID: 30169404 281. Kim C, Kim JS, Kim H, et al. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents. J Am Heart Assoc 2020; 9: e 016218. PMID: 32419586 282. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596- 604. PMID: 18813037 283. Norderud K, Egholm G, Thim T, et al. Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation. Eur Heart J Qual Care Clin Outcomes 2019; 5: 22-27. PMID: 30032304 284. Hawn MT, Graham LA, Richman JR, et al. The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 2012; 214: 658-666. PMID: 22341201 285. Lee OH, Hong SJ, Ahn CM, et al. The Incidence of Non-Cardiac Surgery in Patients Treated With Drug-Eluting Stents According to Age. J Invasive Cardiol 2019; 31: E9-E14. PMID: 30700625 286. Howell SJ, Hoeks SE, West RM, et al. OBTAIN Investigators of European Society of Anaesthesiology (ESA) Clinical Trial Network. Prospective observational cohort study of the associ- ation between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery. Br J Anaesth 2019; 122: 170-179. PMID: 30686302 287. Yamamoto K, Wada H, Sakakura K, et al. Cardiovascular and bleeding risk of non-cardiac surgery in patients on antiplatelet therapy. J Cardiol 2014; 64: 334-338. PMID: 24802171 288. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 2020; 41: 407-477. PMID: 31504439 289. Schoos M, Chandrasekhar J, Baber U, et al. Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). Am J Cardiol 2017; 120: 904- 910. PMID: 28778417 290. Chambers J, Kabir S, Cajeat E. Detection of heart disease by open access echocardiography: a retrospective analysis of general practice referrals. Br J Gen Pract 2014; 64: e105-e111. PMID: 24567615 291. Graham MM, Sessler DI, Parlow JL, et al. Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery. Ann Intern Med 2018; 168: 237- 244. PMID: 29132159 292. Rodriguez A, Guilera N, Mases A, et al. REGISTRESTENTS group. Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events. Br J Anaesth 2018; 120: 67- 76. PMID: 29397139 293. Siller-Matula JM, Petre A, Delle-Karth G, et al. Impact of preoperative use of P 2 Y 1 2 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2017; 6: 753-770. PMID: 25943554 294. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110: 1202-1208. PMID: 15313956 295. Hansson EC, Jidéus L, Åberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016; 37: 189-197. PMID: 26330426 296. Smith PK, Goodnough LT, Levy JH, et al. Mortality benefit with prasugrel in the TRITON-TIMI 3 8 coronary artery bypass grafting cohort: Risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012; 60: 388-396. PMID: 22633653 297. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2018; 53: 34-78. PMID: 29045581 298. Wallentin L. P 2Y 12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009; 30: 1964-1977. PMID: 19633016 299. Tanaka A, Ishii H, Tatami Y, et al. Unfractionated Heparin during the Interruption of Antiplatelet Therapy for Non-cardiac Surgery after Drug-eluting Stent Implantation. Intern Med 2016; 55: 333-337. PMID: 26875956 300. Capodanno D, Musumeci G, Lettieri C, et al. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery. Thromb Haemost 2015; 114: 423- 431. PMID: 26017898 301. Breen P, Lee JW, Pomposelli F, et al. Timing of high-risk vascular surgery following coronary artery bypass surgery: A 10-year experience from an academic medical centre. Anaesthesia 2004; 59: 422-427. PMID: 15096235 302. Mookadam F, Carpenter SD, Thota VR, et al. Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiol 2011; 7: 69- 75. PMID: 21174512 303. Tokushige A, Shiomi H, Morimoto T, et al. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: A report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry